Why is JHS Sven.Lab. falling/rising?

As of 18-Sep, JHS Svendgaard Laboratories Ltd is experiencing a decline in its stock price, currently at 10.64, which reflects a decrease of 0.38 or 3.45%. The stock has underperformed its sector by 3.84% today and has been on a downward trend for the last two days, accumulating a total loss of 5.67% during this period. Additionally, the stock has shown significant underperformance over various time frames, with a staggering 66.75% decline over the past year and a 50.90% drop year-to-date. The company's weak long-term fundamentals are highlighted by a negative compound annual growth rate (CAGR) of -5.77% in operating profits over the last five years and a poor EBIT to interest ratio of -8.00, indicating challenges in servicing its debt. Furthermore, the stock's negative EBITDA and reliance on non-operating income, which constitutes 158.73% of profit before tax, contribute to its unfavorable outlook.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as the Sensex has gained 1.80% over the past week and 6.24% year-to-date. This stark difference underscores the stock's struggles, particularly as it has consistently underperformed against the BSE500 over the last three years, one year, and three months. Despite a rise in investor participation, with delivery volume increasing by 139.57% against the five-day average, the overall sentiment remains negative due to the company's persistent losses and weak financial health.